| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/02/2006 | WO2006021533A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
| 03/02/2006 | WO2006021456A1 Combination comprising a staurosporine and a cyp3a4 inhibitor |
| 03/02/2006 | WO2006021454A2 Pyrimidine derivatives |
| 03/02/2006 | WO2006021379A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | WO2006021378A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | WO2006021335A2 Peptide mixture from peptides having a molecular weight of from 1000 to 5000 dalton |
| 03/02/2006 | WO2006006933A3 Antiproliferative compositions comprising aryl substituted xylopyranoside derivatives |
| 03/02/2006 | WO2005121172A3 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 03/02/2006 | WO2005100990A3 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) |
| 03/02/2006 | WO2005089730A3 Dna pkinase inhibitors for treating cancer and diabetes |
| 03/02/2006 | WO2005019429A3 Compositions and methods for enhancing phagocytosis or phagocyte activity |
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | WO2003090686A3 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060046987 Substituted quinazoline derivatives and their use as inhibitors |
| 03/02/2006 | US20060045853 Using tissue plasminogen activator finger domain specific immunolglobulins as tool in diagnosis of diabbetes and/or alzheimer's disease |
| 03/02/2006 | CA2829654A1 Small molecules that replace or agonize p53 function |
| 03/02/2006 | CA2578838A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | CA2578560A1 Dihydropteridinones, method for the production thereof, and use thereof as a medicament |
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577982A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | CA2577857A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | CA2577676A1 Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil |
| 03/02/2006 | CA2577441E Improved photosensitizer formulations and their use |
| 03/02/2006 | CA2577251A1 Pyrimidine derivatives |
| 03/02/2006 | CA2576747A1 Benzoxazepine derivatives as selective estrogen receptor modulators |
| 03/02/2006 | CA2575804A1 Pteridinones used as plk (polo like kinase) inhibitors |
| 03/02/2006 | CA2573371A1 Pyrimidines as plk inhibitors |
| 03/02/2006 | CA2564224A1 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 03/01/2006 | EP1630229A2 Melanoma antigens |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1630163A1 Dihydropteridinones, methods for their preparation and their use as drugs |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
| 03/01/2006 | EP1629848A1 Apoptosis inducing agent and method of inducing apoptosis |
| 03/01/2006 | EP1629275A2 Method for the selection of epitopes for immunotherapy |
| 03/01/2006 | EP1629012A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 03/01/2006 | EP1629010A1 Treatment with anti-vegf antibodies |
| 03/01/2006 | EP1628999A2 Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628992A2 Methods of modulating metastasis and skeletal related events resulting from metastases |
| 03/01/2006 | EP1628976A1 Novel pyridopyrazines and use thereof as kinase inhibitors |
| 03/01/2006 | EP1628965A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 03/01/2006 | EP1628957A1 Sulfopyrroles |
| 03/01/2006 | EP1628671A1 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
| 03/01/2006 | EP1628651A2 Combination of histone deacetylase inhibitors with chemotherapeutic agents |
| 03/01/2006 | EP1628631A2 Methods of treating hyperproliferative cell disorders |
| 03/01/2006 | EP1628623A2 Method for treating diseases using hsp90-inhibiting agents in combination with enzyme inhibitors |
| 03/01/2006 | EP1628619A2 4-aminopyrimidine-5-one |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP1430059B1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 03/01/2006 | EP1389234B1 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 03/01/2006 | EP1373494B1 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1339399B1 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 03/01/2006 | EP1325739B1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311672B1 tRNA-derived inhibitors of HIV reverse transcriptase |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1290205B1 Duplexed parvovirus vectors |
| 03/01/2006 | EP1290139B1 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
| 03/01/2006 | EP1263475B1 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 03/01/2006 | EP1183033B1 Pyrrolotriazine inhibitors of kinases |
| 03/01/2006 | EP1162991B1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 03/01/2006 | EP1127355B1 Products and methods for brachytherapy |
| 03/01/2006 | EP1086105B1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0956506B1 Treatment and diagnosis of cancer |
| 03/01/2006 | EP0944311B1 Method for antagonizing HEREGUlin or its receptor and use for the inhibition of cancer cells |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | EP0862634B2 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 03/01/2006 | EP0840750B1 Ha-2 antigenic peptide |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | CN1742022A Neuropilin-1 inhibitors |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1741992A 大麻素受体配体 Cannabinoid receptor ligands |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741821A Compositions for cancer treatment |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741805A High protein, bowman-birk inhibitor concentrate and process for its manufacture |
| 03/01/2006 | CN1741804A Freeze-dried preparation of stabilized anthracycline compound |
| 03/01/2006 | CN1740200A Cervical cancer inhibiting fusion protein |
| 03/01/2006 | CN1740197A Recombination interferon with new space conformation and enhanced effect, its preparing method and application |
| 03/01/2006 | CN1740194A One kind of tumor relevant protein and its coding gene and application |
| 03/01/2006 | CN1740187A Application of peininine and its derivative in preparing antitumor medicine |
| 03/01/2006 | CN1740185A Antitumor compound nobiliside A from Holathuria nobilis and its monoacetylated derivative |
| 03/01/2006 | CN1739803A Bioactive peptide specific medicine for recurrent late phase cancer |
| 03/01/2006 | CN1739800A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/01/2006 | CN1739791A Prevention and treatment of hepatocellular cancer |
| 03/01/2006 | CN1739788A Modulation of TRIP-BR function and method of treating proliferative disorders |
| 03/01/2006 | CN1739786A Thymic pentapeptide aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739771A Liver cancer treating medicine |
| 03/01/2006 | CN1739749A Leukemia treating Chinese medicine composition and its prepn |
| 03/01/2006 | CN1739744A Production process of flavone compound powder |
| 03/01/2006 | CN1739706A Tongue dropping medicine pill for diminishing inflammation and detoxicating |
| 03/01/2006 | CN1739684A Dermatosis eliminating medicine |